Here we aimed to perform a comprehensive evaluation of the clinical and MRI correlates of the CSF presence of TNF and its soluble receptors, TNF-R1 and TNF-R2, in treatment-naïve MS patients and the potential association with other inflammatory mediators. The gene discussed is TNFRSF1B; the disease is myeloid sarcoma.